State Key Laboratory of Cardiovascular Disease of China, Hypertension Center, Fuwai Hospital, National Center for Cardiovascular Diseases of China, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Department of Cardiology, Zhongshan Hospital, Fudan University, Shanghai Institute of Cardiovascular Diseases, Shanghai, China.
Front Endocrinol (Lausanne). 2022 Aug 25;13:942647. doi: 10.3389/fendo.2022.942647. eCollection 2022.
It is unclear whether more severe non-alcoholic fatty liver disease (NAFLD) combined with prehypertension or hypertension is associated with a higher risk of cardiovascular events (CVEs). To evaluate the relationship between the severity of NAFLD and CVEs among patients with prehypertension or hypertension.
In this prospective community-based Kailuan cohort, participants without cardiovascular disease and alcohol abuse, or other liver diseases were enrolled. NAFLD was diagnosed by abdominal ultrasonography. Prehypertension was defined as systolic blood pressure (BP) of 120-139 mmHg or diastolic BP of 80-89 mmHg. Participants with NAFLD were divided into mild, moderate, and severe subgroups. Follow-up for CVEs including myocardial infarction, hemorrhagic stroke, and ischemic stroke. The Cox proportional hazards model was used to estimate hazard ratios and 95% CIs of CVEs according to the severity of NAFLD and hypertensive statutes. The C-statistic was used to evaluate the efficiency of models.
A total of 71926 participants (mean [SD] age, 51.83 [12.72] years, 53794 [74.79%] men, and 18132 [25.21%] women) were enrolled in this study, 6,045 CVEs occurred during a median of 13.02 (0.65) years of follow-up. Compared with participants without NAFLD, the hazard ratios of CVEs for patients with mild, moderate, and severe NAFLD were 1.143 (95% CI 1.071-1.221, < 0.001), 1.218 (95% CI 1.071-1.221, < 0.001), and 1.367 (95% CI 1.172-1.595, < 0.001), respectively. Moreover, participants with prehypertension plus moderate/severe NAFLD and those with hypertension plus moderate/severe NAFLD had 1.558-fold (95% CI 1.293-1.877, < 0.001) and 2.357-fold (95% CI 2.063-2.691, < 0.001) higher risks of CVEs, respectively, compared with those with normal BP and no NAFLD. Adding a combination of NAFLD and BP status to the crude Cox model increased the C-statistic by 0.0130 (0.0115-0.0158, < 0.001).
Our findings indicated that the increased cardiovascular risk with elevated BP is largely driven by the coexistence of moderate/severe NAFLD, suggesting that the severity of NAFLD may help further stratify patients with prehypertension and hypertension.
目前尚不清楚非酒精性脂肪性肝病(NAFLD)严重程度合并高血压前期或高血压是否与心血管事件(CVE)风险增加相关。本研究旨在评估高血压前期或高血压患者中 NAFLD 严重程度与 CVE 之间的关系。
在这项前瞻性的基于社区的开滦队列研究中,纳入了没有心血管疾病、酒精滥用或其他肝脏疾病的参与者。通过腹部超声诊断 NAFLD。高血压前期定义为收缩压(BP)为 120-139mmHg 或舒张压为 80-89mmHg。将 NAFLD 患者分为轻度、中度和重度亚组。随访 CVE 包括心肌梗死、出血性卒中和缺血性卒中等。使用 Cox 比例风险模型根据 NAFLD 严重程度和高血压状态评估 CVE 的风险比和 95%置信区间。C 统计量用于评估模型的效率。
本研究共纳入 71926 名参与者(平均[SD]年龄为 51.83[12.72]岁,53794[74.79%]为男性,18132[25.21%]为女性),中位随访 13.02(0.65)年后发生 6045 例 CVE。与无 NAFLD 的参与者相比,轻度、中度和重度 NAFLD 患者的 CVE 风险比分别为 1.143(95%CI 1.071-1.221,<0.001)、1.218(95%CI 1.071-1.221,<0.001)和 1.367(95%CI 1.172-1.595,<0.001)。此外,高血压前期合并中重度 NAFLD 患者和高血压合并中重度 NAFLD 患者的 CVE 风险分别增加 1.558 倍(95%CI 1.293-1.877,<0.001)和 2.357 倍(95%CI 2.063-2.691,<0.001)。与正常血压且无 NAFLD 的患者相比。将 NAFLD 和血压状态的组合添加到粗 Cox 模型中,C 统计量增加了 0.0130(0.0115-0.0158,<0.001)。
我们的研究结果表明,血压升高导致的心血管风险增加在很大程度上是由中重度 NAFLD 共同引起的,这表明 NAFLD 的严重程度可能有助于进一步对高血压前期和高血压患者进行分层。